The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: Analysis in two Chinese populations

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 481-485

  Tong, Yeqing ^a,c   Wang, Zhihong ^a   Geng, Yijie ^b   Liu, Jianping ^b   Zhang, Renli ^b   Lin, Qiang ^b   Li, Xiaoheng ^b   Huang, Dana ^b   Gao, Shitong ^b   Hu, Dandan ^c   Li, Yongbin ^c   Cheng, Jinquan ^b   Lu, Zuxun ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shenzhen Center for Chronic Disease Control   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ethnic population; Functional polymorphisms; IL 6; Ischemic stroke; Promoter

Indexed keywords

GENOMIC DNA; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA EXTRACTION; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STROKE;

EID: 72949091661     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.084     Document Type: Article

References (45)

1. Humphries S.E., and Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol. 3 (2004) 227-235
2. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 6 (2007) 149-161
3. Bova I.Y., Bornstein N.M., and Korczyn A.D. Acute infection as a risk factor for ischemic stroke. Stroke 27 (1996) 2204-2206
4. Grau A.J., Buggle F., Becher H., et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 50 (1998) 196-203
5. Macko R.F., Ameriso S.F., Barndt R., Clough W., Weiner J.M., and Fisher M. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 27 (1996) 1999-2004
6. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
7. Huber S.A., Sakkinen P., Conze D., Hardin N., and Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2364-2367
8. Rus H.G., Vlaicu R., and Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127 (1996) 263-271
9. Schieffer B., Schieffer E., Hilfiker-Kleiner D., et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 101 (2000) 1372-1378
10. Seino Y., Ikeda U., Ikeda M., et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 6 (1994) 87-91
11. Hojo Y., Ikeda U., Takahashi M., and Shimada K. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 161 (2002) 403-408
12. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
13. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
14. Suzuki S., Tanaka K., and Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow Metab. 29 (2009) 464-479
15. Banerjee I., Gupta V., Ahmed T., Faizaan M., Agarwal P., and Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res. Bull. 75 (2008) 158-165
16. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102 (1998) 1369-1376
17. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275 (2000) 18138-18144
18. Yamada Y., Metoki N., Yoshida H., et al. Genetic risk for ischemic and hemorrhagic stroke. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1920-1925
19. Castillo J., and Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc. Dis. 17 Suppl. 1 (2004) 7-18
20. Acalovschi D., Wiest T., Hartmann M., et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34 (2003) 1864-1869
21. Castellanos M., Castillo J., Garcia M.M., et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 33 (2002) 982-987
22. Smith C.J., Emsley H.C., Gavin C.M., et al. Peak plasma interleukin-6, other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity, long-term outcome. BMC Neurol. 4 (2004) 2
23. Perini F., Morra M., Alecci M., Galloni E., Marchi M., and Toso V. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol. Sci. 22 (2001) 289-296
24. Waje-Andreassen U., Krakenes J., Ulvestad E., et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol. Scand. 111 (2005) 360-365
25. Tso A.R., Merino J.G., and Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 38 (2007) 3070-3075
26. Wood P.H. Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron. 34 (1980) 376-380
27. Bamford J., Dennis M., Sandercock P., Burn J., and Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J. Neurol. Neurosurg. Psychiatry 53 (1990) 824-829
28. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
29. Pola R., Flex A., Gaetani E., Flore R., Serricchio M., and Pola P. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 34 (2003) 881-885
30. Licata G., Tuttolomondo A., Raimondo D.D., Corrao S., Sciacca R.D., and Pinto A. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb. Haemost. 101 (2009) 929-937
31. Osiri M., McNicholl J., Moreland L.W., and Bridges Jr. S.L. A novel single nucleotide polymorphism and five probable haplotypes in the 5′ flanking region of the IL-6 gene in African-Americans. Genes Immun. 1 (1999) 166-167
32. Jordanides N., Eskdale J., Stuart R., and Gallagher G. Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus. Genes Immun. 1 (2000) 451-455
33. Ota N., Nakajima T., Nakazawa I., et al. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J. Hum. Genet. 46 (2001) 267-272
34. Chamorro A., Revilla M., Obach V., Vargas M., and Planas A.M. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes. Cerebrovasc. Dis. 19 (2005) 91-95
35. Balding J., Livingstone W.J., Pittock S.J., et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir. J. Med. Sci. 173 (2004) 200-203
36. Lalouschek W., Schillinger M., Hsieh K., et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin. Chem. Lab. Med. 44 (2006) 918-923
37. Strand M., Soderstrom I., Wiklund P.G., et al. Polymorphisms at the osteoprotegerin and interleukin-6 genes in relation to first-ever stroke. Cerebrovasc. Dis. 24 (2007) 418-425
38. Yamada Y., Ichihara S., and Nishida T. Proinflammatory gene polymorphisms and ischemic stroke. Curr. Pharm. Des. 14 (2008) 3590-3600
39. Nibali L., D'Aiuto F., Donos N., et al. Association between periodontitis and common variants in the promoter of the interleukin-6 gene. Cytokine 45 (2009) 50-54
40. Sarecka-Hujar B., Zak I., and Krauze J. Carrier-state of two or three polymorphic variants of MTHFR, IL-6 and ICAM1 genes increases the risk of coronary artery disease. Kardiol. Pol. 66 (2008) 1269-1277
41. Revai K., Patel J.A., Grady J.J., Nair S., Matalon R., and Chonmaitree T. Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media. Clin. Infect. Dis. 49 (2009) 257-261
42. Dema B., Martinez A., Fernandez-Arquero M., et al. The IL6-174G/C polymorphism is associated with celiac disease susceptibility in girls. Hum. Immunol. 70 (2009) 191-194
43. Popko K., Gorska E., Potapinska O., et al. Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF-alpha gene polymorphism in patients with obstructive sleep apnea. J. Physiol. Pharmacol. 59 Suppl. 6 (2008) 607-614
44. Gangwar R., Mittal B., and Mittal R.D. Association of interleukin-6-174G>C promoter polymorphism with risk of cervical cancer. Int. J. Biol. Markers 24 (2009) 11-16
45. Resch B., Radinger A., Mannhalter C., Binder A., Haas J., and Muller W.D. Interleukin-6 G(-174)C polymorphism is associated with mental retardation in cystic periventricular leucomalacia in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 94 (2009) F304-F306